You may be right about the drop in market share if all that is considered is bare cost. Generic "Prozac" is cheaper than Celexa. The only crimp in that is that Celexa has specific benefits. I'm a therapist and have and have had quite a few patients on Celexa for the past 15 months. Most of them report fewer side effects than when on Prozac. While the HMO's are not entirely on board because of the cost, the fact is that celexa is and will be the mid-term drug of choice for treating depression in the elderly because it doesn't combine with other medications as readily as the rest of the SSRI group. Pure pricing might win out but a strong senior lobby with physicians wanting to prescribe what they actually think will work best may swing the battle in the direction of Celexa.
Look at James Cramer's pick SVNX and other garbage. His street.com is nosense too.
When Hoffamn keep buy HYSQ CRGN INCY I shorted it.
Please remember there is not only one generic company to manufacture Generic Prozac but many (at 5) to sell generic Prozac at 1/4 of Prozac price which will make FRX's growth negative. Currently FRX has 15% SSRI and it will drop to %5 marekt share by end 2001.
soon will have Generic Clexa. Clexa is a off-patent drug too. Therefore generic companis can develop generic version in advance. Please remeber that there are many (>5) generic companies will market generic Prozac and Clexa in 2001. FRX's earning will drop sharply. Also those newly licensed compounds are still 2-3 years away from marketing.